Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium-or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire

This publication has 23 references indexed in Scilit:

• Long–term survival in trial of medium–titre Edmonston–Zagreb measles vaccine in Guinea–Bissau: five–year follow–up
  Epidemiology and Infection, 1994
• Lessons from measles vaccination in developing countries.
  BMJ, 1993
• Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: Increased female mortality rate
  The Journal of Pediatrics, 1993
• Increased mortality after high titer measles vaccines
  The Pediatric Infectious Disease Journal, 1993
• Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants
  The Pediatric Infectious Disease Journal, 1992
• The 1st International Standard for anti-measles serum
  Biologicals, 1991
• Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine
  The Pediatric Infectious Disease Journal, 1991
• Immunization of Six-Month-Old Infants with Different Doses of Edmonston–Zagreb and Schwarz Measles Vaccines
  New England Journal of Medicine, 1990
• SEROLOGICAL EFFECTS OF EDMONSTON-ZAGREB, SCHWARZ, AND AIK-C MEASLES VACCINE STRAINS GIVEN AT AGES 4-5 OR 8-10 MONTHS
  The Lancet, 1989
• Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization
  The Journal of Pediatrics, 1979